Issue Number 17                                           August 31, 1998

CONTENTS OF THIS ISSUE

1. ROTAVIRUS VACCINE LICENSE APPLICATION IS APPROVED BY FDA
--------------------------------------------------------

(1)
August 31, 1998
ROTAVIRUS VACCINE LICENSE APPLICATION IS APPROVED BY FDA

On August 31, 1998, the FDA approved a license application for rotavirus vaccine, live, oral, tetravalent.  RotaShield is the trade name of this vaccine. RotaShield is indicated for the prevention of gastroenteritis caused by those rotavirus serotypes contained in the vaccine. The recommended dosing schedule for oral immunization with RotaShield is 2, 4, and 6 months of age. Initiation of vaccination after 6 months of age is currently not recommended.

RotaShield is manufactured by Wyeth Laboratories, Inc. of Marietta, Pennsylvania, and distributed by Wyeth-Lederle Vaccines and Pediatrics. Please see the package insert for additional information.

About IZ Express

IZ Express is supported in part by Grant No. NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

Editorial Information

  • Editor-in-Chief
    Kelly L. Moore, MD, MPH
  • Managing Editor
    John D. Grabenstein, RPh, PhD
  • Associate Editor
    Sharon G. Humiston, MD, MPH
  • Writer/Publication Coordinator
    Taryn Chapman, MS
    Courtnay Londo, MA
  • Style and Copy Editor
    Marian Deegan, JD
  • Web Edition Managers
    Arkady Shakhnovich
    Jermaine Royes
  • Contributing Writer
    Laurel H. Wood, MPA
  • Technical Reviewer
    Kayla Ohlde

This page was updated on .